Serotonergic and dopaminergic modulation of attentional processes

Progress in Brain Research

Volumn 172, Issue , 2008, Pages 517-542

  Boulougouris, Vasileios ^a   Tsaltas, Eleftheria ^b  

^a UK   (United Kingdom)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

5CSRTT; attention; dopamine; inhibition; serotonin; shifting

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; AMPHETAMINE; ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; FLUPENTIXOL; KETAMINE; LEVODOPA; METHYLPHENIDATE; NEUROTRANSMITTER; PHENCYCLIDINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SULPIRIDE; TOLCAPONE; VOLINANSERIN;

ALERTNESS; AMNESIA; ATTENTION; ATTENTION DEFICIT DISORDER; BEHAVIOR; COGNITION; DOPAMINERGIC SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUNTINGTON CHOREA; IMPULSIVENESS; NEUROCHEMISTRY; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROMODULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PERFORMANCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOPATHY; REACTION TIME; REVIEW; SCHIZOPHRENIA; SELECTIVE ATTENTION; SEROTONINERGIC SYSTEM;

ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COGNITION DISORDERS; DOPAMINE; DOPAMINE AGENTS; HUMANS; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE; SEROTONIN; SEROTONIN AGENTS; VISUAL CORTEX;

EID: 50349095947     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)00925-4     Document Type: Review

References (177)

1. Alexander G.E., DeLong M.R., and Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9 (1986) 357-381
2. Amat J., Baratta M.V., Paul E., Bland S.T., Watkins L.R., and Maier S.F. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat. Neurosci. 8 3 (2005) 365-371
3. Anderson I.M., Clark L., Elliott R., Kulkarni B., Williams S.R., and Deakin J.F. 5-HT(2C) receptor activation by m-chlorophenylpiperazine detected in humans with fMRI. Neuroreport 13 12 (2002) 1547-1551
4. Andreasen N.C., Paradiso S., and O'Leary D.S. "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?. Schizophr. Bull. 24 2 (1998) 203-218
5. Arnsten A.F. Catecholamine regulation of the prefrontal cortex. J. Psychopharmacol. 11 2 (1997) 151-162
6. Arnsten A.F.T., and Robbins T.W. Neurochemical modulation of prefrontal cortical functions in humans and animals. In: Stuss D., and Knight R. (Eds). The Prefrontal Cortex (2002), Oxford University Press, New York, NY 51-84
7. Aron A.R., Dowson J.H., Sahakian B.J., and Robbins T.W. Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol. Psychiatry 54 12 (2003) 1465-1468
8. Aron A.R., Fletcher P.C., Bullmore E.T., Sahakian B.J., and Robbins T.W. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat. Neurosci. 6 2 (2003) 115-116
9. Aron A.R., and Poldrack R.A. Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus. J. Neurosci. 26 9 (2006) 2424-2433
10. Aron A.R., Robbins T.W., and Poldrack R.A. Inhibition and the right inferior frontal cortex. Trends Cogn. Sci. 8 4 (2004) 170-177
11. Aylward E.H., Anderson N.B., Bylsma F.W., Wagster M.V., Barta P.E., Sherr M., Feeney J., Davis A., Rosenblatt A., Pearlson G.D., and Ross C.A. Frontal lobe volume in patients with Huntington's disease. Neurology 50 1 (1998) 252-258
12. Band G.P.H., and van Boxtel G.J.M. Inhibitory motor control in stop paradigms: review and reinterpretation of neural mechanisms. Acta Psychol. 101 2-3 (1999) 179-211
13. Baunez C., and Robbins T.W. Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat. Neuroscience 92 4 (1999) 1343-1356
14. Bonvento G., Scatton B., Claustre Y., and Rouquier L. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neurosci. Lett. 137 1 (1992) 101-104
15. Boulougouris V., Dalley J.W., and Robbins T.W. Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behav. Brain Res. 179 2 (2007) 219-228
16. Boulougouris, V., Glennon, J.C. and Robbins, T.W. (2007b) Dissociable effects of selective 5-HT(2A) and 5-HT(2C) receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacology, In press, doi:10.1038/sj.npp.1301584.
17. Brown R.G., and Marsen C.D. Subcortical dementia: the neuropsychological evidence. Neuroscience 25 2 (1988) 363-387
18. Brown V.J., and Bowman E.M. Rodent models of prefrontal cortical function. Trends Neurosci. 25 7 (2002) 340-343
19. Carli M., Baviera M., Invernizzi R.W., and Balducci C. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology 31 4 (2006) 757-767
20. Carli M., and Samanin R. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors. Psychopharmacology (Berl.) 149 3 (2000) 259-268
21. Castner S.A., Williams G.V., and Goldman-Rakic P.S. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science 287 5460 (2000) 2020-2022
22. Celada P., Puig M.V., Casanovas J.M., Guillazo G., and Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors. J. Neurosci. 21 24 (2001) 9917-9929
23. Chamberlain S.R., Muller U., Blackwell A.D., Clark L., Robbins T.W., and Sahakian B.J. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311 5762 (2006) 861-863
24. Chamberlain S.R., Muller U., Deakin J.B., Corlett P.R., Dowson J., Cardinal R., Aitken M.R., Robbins T.W., and Sahakian B.J. Lack of deleterious effects of buspirone on cognition in healthy male volunteers. J. Psychopharmacol. 21 2 (2006) 210-215
25. Chao L.L., and Knight R.T. Human prefrontal lesions increase distractibility to irrelevant sensory inputs. Neuroreport 6 12 (1995) 1605-1610
26. Christakou A., Robbins T.W., and Everitt B.J. Functional disconnection of a prefrontal cortical-dorsal striatal system disrupts choice reaction time performance: implications for attentional function. Behav. Neurosci. 115 4 (2001) 812-825
27. Chudasama Y., and Muir J.L. Visual attention in the rat: a role for the prelimbic cortex and thalamic nuclei?. Behav. Neurosci. 115 2 (2001) 417-428
28. Chudasama Y., Passetti F., Rhodes S.E., Lopian D., Desai A., and Robbins T.W. Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav. Brain Res. 146 1-2 (2003) 105-119
29. Chudasama Y., and Robbins T.W. Dissociable contributions of the orbitofrontal and infralimbic cortex to pavlovian autoshaping and discrimination reversal learning: further evidence for the functional heterogeneity of the rodent frontal cortex. J. Neurosci. 23 25 (2003) 8771-8780
30. Chudasama Y., and Robbins T.W. Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl.) 174 1 (2004) 86-98
31. Clarke H.F., Dalley J.W., Crofts H.S., Robbins T.W., and Roberts A.C. Cognitive inflexibility after prefrontal serotonin depletion. Science 304 5672 (2004) 878-880
32. Clarke H.F., Walker S.C., Crofts H.S., Dalley J.W., Robbins T.W., and Roberts A.C. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J. Neurosci. 25 2 (2005) 532-538
33. Clarke H.F., Walker S.C., Dalley J.W., Robbins T.W., and Roberts A.C. Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cereb. Cortex 17 1 (2007) 18-27
34. Cohen J.D., Braver T.S., and O'Reilly R.C. A computational approach to prefrontal cortex, cognitive control and schizophrenia: recent developments and current challenge. In: Roberts A.C., Robbins T.W., and Weiskrantz L. (Eds). The Prefrontal Cortex: Executive and Cognitive Functions (1999), Oxford University Press, New York 195-220
35. Cole B.J., and Robbins T.W. Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology (Berl.) 91 4 (1987) 458-466
36. Cole B.J., and Robbins T.W. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav. Brain Res. 33 2 (1989) 165-179
37. Collins P., Roberts A.C., Dias R., Everitt B.J., and Robbins T.W. Perseveration and strategy in a novel spatial self-ordered sequencing task for nonhuman primates: effects of excitotoxic lesions and dopamine depletions of the prefrontal cortex. J. Cogn. Neurosci. 10 3 (1998) 332-354
38. Consolo S., Ramponi S., Ladinsky H., and Baldi G. A critical role for D1 receptors in the 5-HT1A-mediated facilitation of in vivo acetylcholine release in rat frontal cortex. Brain Res. 707 2 (1996) 320-323
39. Cools R., Barker R.A., Sahakian B.J., and Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb. Cortex 11 (2002) 1136-1143
40. Cools R., Clark L., Owen A.M., and Robbins T.W. Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J. Neurosci. 22 11 (2002) 4563-4567
41. Cools R., Clark L., and Robbins T.W. Differential responses in human striatum and prefrontal cortex to changes in object and rule relevance. J. Neurosci. 24 5 (2004) 1129-1135
42. Cools R., Ivry R.B., and D'Esposito M. The human striatum is necessary for responding to changes in stimulus relevance. J. Cogn. Neurosci. 18 12 (2006) 1973-1983
43. Crofts H.S., Dalley J.W., Collins P., Van Denderen J.C., Everitt B.J., Robbins T.W., and Roberts A.C. Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. Cereb. Cortex 11 11 (2001) 1015-1026
44. Dalley J.W., Theobald D.E., Eagle D.M., Passetti F., and Robbins T.W. Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology 26 6 (2002) 716-728
45. Dalley J.W., Theobald D.E., Pereira E.A., Li P.M., and Robbins T.W. Specific abnormalities in serotonin release in the prefrontal cortex of isolation-reared rats measured during behavioural performance of a task assessing visuospatial attention and impulsivity. Psychopharmacology (Berl.) 164 3 (2002) 329-340
46. Damasio A.R. The somatic marker hypothesis and the possible functions of the prefrontal cortex. In: Roberts A.C., Robbins T.W., and Weiskrantz L. (Eds). The Prefrontal Cortex: Executive and Cognitive Functions (1998), Oxford University Press, New York 195-220
47. Day J., and Fibiger H.C. Dopaminergic regulation of cortical acetylcholine release: effects of dopamine receptor agonists. Neuroscience 54 3 (1993) 643-648
48. Decary A., and Richer F. Response selection deficits in frontal excisions. Neuropsychologia 33 10 (1995) 1243-1253
49. Del-Ben C.M., Deakin J.F., McKie S., Delvai N.A., Williams S.R., Elliott R., Dolan M., and Anderson I.M. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 30 9 (2005) 1724-1734
50. Di Matteo V., De Blasi A., Di Giulio C., and Esposito E. Role of 5-HT2C receptors in the control of central dopamine function. Trends Pharmacol. Sci. 22 5 (2001) 229-232
51. Di Matteo V., Di Giovanni G., Di Mascio M., and Esposito E. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors. Brain Res. 865 1 (2000) 85-90
52. Dias R., Robbins T.W., and Roberts A.C. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 380 6569 (1996) 69-72
53. Dias R., Robbins T.W., and Roberts A.C. Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: restriction to novel situations and independence from "on-line" processing. J. Neurosci. 17 23 (1997) 9285-9297
54. Drewe E. Go-no go learning after frontal lobe lesions in humans. Cortex 11 1 (1975) 8-16
55. Dubois B., Boller F., Pillon B., and Agid Y. Cognitive deficits in Parkinson's disease. In: Boller F., and Grafman J. (Eds). Handbook of Neuropsychology Vol. 5 (1991), Elsevier, Amsterdam
56. Eagle D.M., Baunez C., Hutcheson D.M., Lehmann O., Shah A.P., and Robbins T.W. Stop-signal reaction time task performance: role of prefrontal cortex and subthalamic nucleus. Cereb. Cortex 18 1 (2007) 178-185
57. Eagle D.M., and Robbins T.W. Lesions of the medial prefrontal cortex or nucleus accumbens core do not impair inhibitory control in rats performing a stop-signal reaction time task. Behav. Brain Res. 146 1-2 (2003) 131-144
58. Eagle D.M., Tufft M.R., Goodchild H.L., and Robbins T.W. Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl.) 192 2 (2007) 193-206
59. Ernst M., Zametkin A.J., Matochik J.A., Jons P.H., and Cohen R.M. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J. Neurosci. 18 15 (1998) 5901-5907
60. Evers E.A., Cools R., Clark L., van der Veen F.M., Jolles J., Sahakian B.J., and Robbins T.W. Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology 30 6 (2005) 1138-1147
61. Fellows L.K., and Farah M.J. Ventromedial frontal cortex mediates affective shifting in humans: evidence from a reversal learning paradigm. Brain 126 (2003) 1830-1837
62. Fillmore M.T., Rush C.R., and Hays L. Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend. 67 2 (2002) 157-167
63. Fletcher P.J., Grottick A.J., and Higgins G.A. Differential effects of the 5-HT2A receptor antagonist M100,907 and the 5-HT2C receptor antagonist SB 242,084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27 4 (2002) 576-586
64. Floresco S.B., Magyar O., Ghods-Sharifi S., Vexelman C., and Tse M.T. Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting. Neuropsychopharmacology 31 2 (2006) 297-309
65. Florijn W.J., Tarazi F.I., and Creese I. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. J. Pharmacol. Exp. Ther. 280 2 (1997) 561-569
66. Folstein S.E., Brandt J., and Folstein M.F. Huntington's disease. In: Cummings J.L. (Ed). Subcortical Dementia (1990), Oxford University Press, New York
67. Frank M.J., Santamaria A., O'Reilly R.C., and Willcutt E. Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder. Neuropsychopharmacology 32 7 (2006) 1583-1599
68. Freedman M. Parkinson's disease. In: Cummings J.L. (Ed). Subcortical Dementia (1990), Oxford University Press, New York
69. Fuster J. The Prefrontal Cortex (1989), Raven Press, New York
70. Gauggel S., Rieger M., and Feghoff T.A. Inhibition of ongoing responses in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 75 4 (2004) 539-544
71. Gobert A., and Millan M.J. Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38 2 (1999) 315-317
72. Gobert A., Rivet J.M., Lejeune F., Newman-Tancredi A., Adhumeau-Auclair A., Nicolas J.P., Cistarelli L., Melon C., and Millan M.J. Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36 3 (2000) 205-221
73. Godefroy O., and Rousseaux M. Divided and focused attention in patients with lesion of the prefrontal cortex. Brain Cogn. 30 2 (1996) 155-174
74. Goldman-Rakic P.S. The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. In: Roberts A.C., Robbins T.W., and Weiskrantz L. (Eds). The Prefrontal Cortex: Executive and Cognitive Functions (1998), Oxford University Press, Oxford, UK 87-102
75. Granon S., Passetti F., Thomas K.L., Dalley J.W., Everitt B.J., and Robbins T.W. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J. Neurosci. 20 3 (2000) 1208-1215
76. Haber S.N., Fudge J.L., and McFarland N.R. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J. Neurosci. 20 6 (2000) 2369-2382
77. Hajós M., Hajós-Korcsok E., and Sharp T. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Br. J. Pharmacol. 126 8 (1999) 1741-1750
78. Hampshire A., and Owen A.M. Fractionating attentional control using event-related fMRI. Cereb. Cortex 16 12 (2006) 1679-1689
79. Harrison A.A., Everitt B.J., and Robbins T.W. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berl.) 133 4 (1997) 329-342
80. Harrison A.A., Everitt B.J., and Robbins T.W. Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination. Behav. Brain Res. 100 (1999) 99-112
81. Hausknecht, K.A., San George, M., Gancarz, A.M., Ashrafioun, L., De Wit, H., Zhuang, Z. and Richards, J.B. (2006) Impulsivity in serotonin transporter knock-out mice: effects of methylphenidate, Society for Neuroscience 2006, Atlanta.
82. Higgins G.A., Enderlin M., Haman M., and Fletcher P.J. The 5-HT2A receptor antagonist M100,907 attenuates motor and "impulsive-like" behaviours produced by NMDA receptor antagonism. Psychopharmacology (Berl.) 170 (2003) 309-319
83. Hollander E., and Rosen J. Impulsivity. J. Psychopharmacol. 14 (2000) S39-S44
84. Hornak J., O'Doherty J., Bramham J., Rolls E.T., Morris R.G., Bullock P.R., and Polkey C.E. Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans. J. Cogn. Neurosci. 16 3 (2004) 463-478
85. Huber S.J., and Shuttleworth E.C. Neuropsychological assessment of subcortical dementia. In: Cummings J.L. (Ed). Subcortical Dementia (1990), Oxford University Press, New York
86. Idris N.F., Repeto P., Neill J.C., and Large C.H. Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat. Psychopharmacology (Berl.) 179 2 (2005) 336-348
87. Inase M., Li B.M., and Tanji J. Dopaminergic modulation of neuronal activity in the monkey putamen through D1 and D2 receptors during a delayed Go/Nogo task. Exp. Brain Res. 117 (1997) 207-218
88. Iversen S.D., and Mishkin M. Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity. Exp. Brain Res. 11 4 (1970) 376-386
89. Jacobs D.M., Levy G., and Marder K. Dementia in Parkinson's disease, Huntington's disease and related disorders. In: Feinberg T.E., and Farah M.J. (Eds). Behavioral Neurology and Neuropsychology. 2nd edn. (2003), McGraw Hill, New York
90. Jin J., Yamamoto T., and Watanabe S. The involvement of sigma receptors in the choice reaction performance deficits induced by phencyclidine. Eur. J. Pharmacol. 319 2-3 (1997) 147-152
91. Jones B., and Mishkin M. Limbic lesions and the problem of stimulus-reinforcement associations. Exp. Neurol. 36 2 (1972) 362-377
92. Kirkby D.L., and Higgins G.A. Characterization of perforant path lesions in rodent models of memory and attention. Eur. J. Neurosci. 10 3 (1998) 823-838
93. Koechlin E., Ody C., and Kouneiher F. The architecture of cognitive control in the human prefrontal cortex. Science 302 5648 (2003) 1181-1185
94. Koskinen T., Ruotsalainen S., Puumala T., Lappalainen R., Koivisto E., Männistö P.T., and Sirviö J. Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology 39 3 (2000) 471-481
95. Kruzich P.J., and Grandy D.K. Dopamine D2 receptors mediate two-odor discrimination and reversal learning in C57BL/6 mice. BMC Neurosci. 5 (2004) 12
96. Kuroki T., Meltzer H.Y., and Ichikawa J. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J. Pharmacol. Exp. Ther. 288 2 (1999) 774-781
97. Lange K.W., Robbins T.W., Marsden C.D., James M., Owen A.M., and Paul G.M. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl.) 107 2-3 (1992) 394-404
98. Lange K.W., Sahakian B.J., Quinn N.P., Marsden C.D., and Robbins T.W. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J. Neurol. Neurosurg. Psychiatry 58 5 (1995) 598-606
99. Langley K., Marshall L., van den Bree M., Thomas H., Owen M., O'Donovan M., and Thapar A. Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am. J. Psychiatry 161 1 (2004) 133-138
100. Lee B., Groman S., London E.D., and Jentsch J.D. Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys. Neuropsychopharmacology 32 10 (2007) 2125-2134
101. Lewis S.J., Slabosz A., Robbins T.W., Barker R.A., and Owen A.M. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Neuropsychologia 43 6 (2005) 823-832
102. Lidow M.S., Elsworth J.D., and Goldman-Rakic P.S. Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. J. Pharmacol. Exp. Ther. 281 1 (1997) 597-603
103. Lidow M.S., and Goldman-Rakic P.S. A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 91 10 (1994) 4353-4356
104. Lidow M.S., Williams G.V., and Goldman-Rakic P.S. The cerebral cortex: a case for a common site of action of antipsychotics. Trends Pharmacol. Sci. 19 4 (1998) 136-140
105. Linnoila M., Virkkunen M., Scheinin M., Nuutila A., Rimon R., and Goodwin F.K. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 33 26 (1983) 2609-2614
106. Logan G.D., and Cowan W.B. On the ability to inhibit thought and action: a theory of an act of control. Psychol. Rev. 91 2 (1984) 295-327
107. MacLeod C.M., Dodd M.D., Sheard E.D., Wilson D.E., and Bibi U. In opposition to inhibition. In: Ross B.H. (Ed). The Psychology of Learning and Motivation (2003), Academic Press, San Diego, CA 163-214
108. Masaki D., Yokoyama C., Kinoshita S., Tsuchida H., Nakatomi Y., Yoshimoto K., and Fukui K. Relationship between limbic and cortical 5-HT neurotransmission and acquisition and reversal learning in a go/no-go task in rats. Psychopharmacology (Berl.) 189 2 (2006) 249-258
109. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., Kolachana B., Callicott J.H., and Weinberger D.R. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc. Natl. Acad. Sci. U.S.A. 100 10 (2003) 6186-6191
110. Mehta M.A., Manes F.F., Magnolfi G., Sahakian B.J., and Robbins T.W. Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology (Berl.) 176 3-4 (2004) 331-342
111. Mehta M.A., Sahakian B.J., McKenna P.J., and Robbins T.W. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Psychopharmacology (Berl.) 146 2 (1999) 162-174
112. Mehta M.A., Swainson R., Ogilvie A.D., Sahakian J., and Robbins T.W. Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers. Psychopharmacology (Berl.) 159 1 (2001) 10-20
113. Meltzer H.Y. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21 (1999) 106S-115S
114. Meltzer H.Y., Matsubara S., and Lee J.C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J. Pharmacol. Exp. Ther. 251 1 (1989) 238-246
115. Millan M.J. Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors. J. Pharmacol. Exp. Ther. 295 3 (2000) 853-861
116. Millan M.J., Dekeyne A., and Gobert A. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37 7 (1998) 953-955
117. Miller E.K., and Cohen J.D. An integrative theory of prefrontal cortex function. Annu. Rev. Neurosci. 24 (2001) 167-202
118. Moghaddam B., and Bunney B.S. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J. Neurochem. 54 5 (1990) 1755-1760
119. Muir J.L., Everitt B.J., and Robbins T.W. The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb. Cortex 6 3 (1996) 470-481
120. Nomura M., and Nomura Y. Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans. Ann. N.Y. Acad. Sci. 1086 (2006) 134-143
121. Nosarti C., Rubia K., Smith A.B., Frearson S., Williams S.C., Rifkin L., and Murray R.M. Altered functional neuroanatomy of response inhibition in adolescent males who were born very preterm. Dev. Med. Child Neurol. 48 4 (2006) 265-271
122. O'Doherty J., Critchley H., Deichmann R., and Dolan R.J. Dissociating valence of outcome from behavioral control in human orbital and ventral prefrontal cortices. J. Neurosci. 23 21 (2003) 7931-7939
123. O'Doherty J., Kringelbach M.L., Rolls E.T., Hornak J., and Andrews C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat. Neurosci. 4 1 (2001) 95-102
124. O'Neill M., and Brown V.J. The effect of striatal dopamine depletion and the adenosine A2A antagonist KW-6002 on reversal learning in rats. Neurobiol. Learn Mem. 88 1 (2007) 75-81
125. Overtoom C.C., Verbaten M.N., Kemner C., Kenemans J.L., van Engeland H., Buitelaar J.K., van der Molen M.W., van der Gugten J., Westenberg H., Maes R.A., and Koelega H.S. Effects of methylphenidate, desipramine, and l-dopa on attention and inhibition in children with attention deficit hyperactivity disorder. Behav. Brain Res. 145 1-2 (2003) 7-15
126. Owen A.M., James M., Leigh P.N., Summers B.A., Marsden C.D., Quinn N.P., Lange K.W., and Robbins T.W. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 115 (1992) 1727-1751
127. Owen A.M., Roberts A.C., Hodges J.R., Summers B.A., Polkey C.E., and Robbins T.W. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 116 (1993) 1159-1175
128. Owen A.M., Roberts A.C., Polkey C.E., Sahakian B.J., and Robbins T.W. Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 29 10 (1991) 993-1006
129. Parasuraman R. The attentive brain: issues and concepts. In: Parasuraman R. (Ed). The Attentive Brain (1998), MIT Press, Cambridge, MA 3-15
130. Parasuraman R., and Davies D.R. A taxonomic analysis of vigilance. In: Mackie R.R. (Ed). Vigilance, Theory, Operational Performance and Physiological Correlates (1977), Plenum Press, New York
131. Park S.B., Coull J.T., McShane R.H., Young A.H., Sahakian B.J., Robbins T.W., and Cowen P.J. Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 33 3-4 (1994) 575-588
132. Passetti F., Chudasama Y., and Robbins T.W. The frontal cortex of the rat and visual attentional performance: dissociable functions of distinct medial prefrontal subregions. Cereb. Cortex 12 12 (2002) 1254-1268
133. Passetti F., Levita L., and Robbins T.W. Sulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions. Behav. Brain Res. 138 1 (2003) 59-69
134. Petrides M. Specialized systems for the processing of mnemonic information within the primate frontal cortex. In: Roberts A.C., Robbins T.W., and Weiskrantz L. (Eds). The Prefrontal Cortex: Executive and Cognitive Functions (1998), Oxford University Press, Oxford, UK 103-114
135. Pincus J.T., and Tucker G. Behavioral Neurology. 4th edn. (2003), Oxford University Press, New York
136. Preuss T.M. Do rats have a prefrontal cortex? The Rose-Woolsey-Akert Program reconsidered. J. Cogn. Neurosci. 7 (1995) 1-24
137. Rahman S., Sahakian B.J., Hodges J.R., Rogers R.D., and Robbins T.W. Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain 122 (1999) 1469-1493
138. Ridley R.M., Haystead T.A., and Baker H.F. An analysis of visual object reversal learning in the marmoset after amphetamine and haloperidol. Pharmacol. Biochem. Behav. 14 3 (1981) 345-351
139. Rieger M., Gauggel S., and Burmeister K. Inhibition of ongoing responses following frontal, nonfrontal, and basal ganglia lesions. Neuropsychology 17 2 (2003) 272-282
140. Robbins T.W. Dissociable executive functions of the prefrontal cortex. In: Roberts A.C., Robbins T.W., and Weiskrantz L. (Eds). The Prefrontal Cortex: Executive and Cognitive Functions (1998), Oxford University Press, Oxford, UK 117-130
141. Robbins T.W. Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp. Brain Res. 133 1 (2000) 130-138
142. Robbins T.W. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl.) 163 3-4 (2002) 362-380
143. Robbins T.W. Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J. Comp. Neurol. 493 1 (2005) 140-146
144. Robbins T.W. Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos. Trans. R. Soc. Lond. B Biol. Sci. 362 1481 (2007) 917-932
145. Robbins T.W., and Everitt B.J. Functions of dopamine in the dorsal and ventral striatum. In: Robbins T.W. (Ed). Seminars in the Neurosciences (1992), Saunders, London, UK 119-127
146. Robbins T.W., Muir J.L., Killcross A.S., and Pretsell D. Methods for assessing attention and stimulus control in the rat. In: Sahgal A. (Ed). Behavioural Neuroscience: A Practical Approach Vol. 1 (1993), Oxford University Press, New York 13-47
147. Robbins T.W., and Roberts A.C. Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cereb. Cortex 17 Suppl. 1 (2007) 151-160
148. Roberts A.C., De Salvia M.A., Wilkinson L.S., Collins P., Muir J.L., Everitt B.J., and Robbins T.W. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J. Neurosci. 14 (1994) 2531-2544
149. Rogers R.D., Andrews T.C., Grasby P.M., Brooks D.J., and Robbins T.W. Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. J. Cogn. Neurosci. 12 1 (2000) 142-162
150. Rogers R.D., Blackshaw A.J., Middleton H.C., Matthews K., Hawtin K., Crowley C., Hopwood A., Wallace C., Deakin J.F., Sahakian B.J., and Robbins T.W. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berl.) 146 4 (1999) 482-491
151. Rosvold H.E., Mirsky A.F., Sarason I., Bransome E.B., and Beck L.H. A continuous performance test of brain damage. J. Consult. Psychol. 20 5 (1956) 343-350
152. Rubia K., Lee F., Cleare A.J., Tunstall N., Fu C.H., Brammer M., and McGuire P. Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI. Psychopharmacology (Berl.) 179 4 (2005) 791-803
153. Rubia K., Oosterlaan J., Sergeant J.A., Brandeis D., and v Leeuwen T. Inhibitory dysfunction in hyperactive boys. Behav. Brain Res. 94 1 (1998) 25-32
154. Rubia K., Overmeyer S., Taylor E., Brammer M., Williams S.C., Simmons A., Andrew C., and Bullmore E.T. Functional frontalisation with age: mapping neurodevelopmental trajectories with fMRI. Neurosci. Biobehav. Rev. 24 1 (2000) 13-19
155. Rubia K., Russell T., Overmeyer S., Brammer M.J., Bullmore E.T., Sharma T., Simmons A., Williams S.C., Giampietro V., Andrew C.M., and Taylor E. Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. Neuroimage 13 2 (2001) 250-261
156. Rubia K., and Smith A. The neural correlates of cognitive time management: a review. Acta Neurobiol. Exp. (Warsaw) 64 3 (2004) 329-340
157. Rubia K., Smith A.B., Brammer M.J., Toone B., and Taylor E. Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. Am. J. Psychiatry 162 6 (2005) 1067-1075
158. Schoenbaum G., Nugent S.L., Saddoris M.P., and Setlow B. Orbitofrontal lesions in rats impair reversal but not acquisition of go, no-go odor discriminations. Neuroreport 13 6 (2002) 885-890
159. Schultz W., and Dickinson A. Neuronal coding of prediction errors. Annu. Rev. Neurosci. 23 (2000) 473-500
160. Shallice T. Specific impairments of planning. Philos. Trans. R. Soc. Lond. B Biol. Sci. 298 1089 (1982) 199-209
161. Solanto M.V., Abikoff H., Sonuga-Barke E., Schachar R., Logan G.D., Wigal T., Hechtman L., Hinshaw S., and Turkel E. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD. J. Abnorm. Child Psychol. 29 3 (2001) 215-228
162. Soubrié P. Serotonergic neurons and behavior. J. Pharmacol. 17 2 (1986) 107-112
163. Steele T.D., Hodges Jr. D.B., Levesque T.R., and Locke K.W. D1 agonist dihydrexidine releases acetylcholine and improves cognitive performance in rats. Pharmacol. Biochem. Behav. 58 2 (1997) 477-483
164. Steinpreis R.E. The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modelling psychosis. Behav. Brain Res. 74 (1996) 45-55
165. Sullivan E.V., Lim K.O., Mathalon D., Marsh L., Beal D.M., Harris D., Hoff A.L., Faustman W.O., and Pfefferbaum A. A profile of cortical gray matter volume deficits characteristic of schizophrenia. Cereb. Cortex 8 2 (1998) 117-124
166. Sutherland N.S., and Mackintosh N.J. Mechanisms of Animal Discrimination Learning (1971), Academic Press, New York, NY
167. Talbot P.S., Watson D.R., Barrett S.L., and Cooper S.J. Rapid tryptophan depletion improves decision-making cognition in healthy humans without affecting reversal learning or set shifting. Neuropsychopharmacology 31 7 (2006) 1519-1525
168. Tamminga C.A., Thaker G.K., and Medoff D.R. Neuropsychiatric aspects of schizophrenia. In: Yudofski S.C., and Hales R.E. (Eds). Textbook of Neuropsychiatry and Clinical Neuroscience (2002), American Psychiatric Publishing, Washington, DC
169. Tunbridge E.M., Bannerman D.M., Sharp T., and Harrison P.J. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J. Neurosci. 24 23 (2004) 5331-5335
170. Vaidya C.J., Austin G., Kirkorian G., Ridlehuber H.W., Desmond J.E., Glover G.H., and Gabrieli J.D. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc. Natl. Acad. Sci. U.S.A. 95 24 (1998) 14494-14499
171. van den Wildenberg W.P., van Boxtel G.J., van der Molen M.W., Bosch D.A., Speelman J.D., and Brunia C.H. Stimulation of the subthalamic region facilitates the selection and inhibition of motor responses in Parkinson's disease. J. Cogn. Neurosci. 18 4 (2006) 626-636
172. Vollm B., Richardson P., McKie S., Elliott R., Deakin J.F., and Anderson I.M. Serotonergic modulation of neuronal responses to behavioural inhibition and reinforcing stimuli: an fMRI study in healthy volunteers. Eur. J. Neurosci. 23 2 (2006) 552-560
173. Wade T.R., de Wit H., and Richards J.B. Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology (Berl.) 150 1 (2000) 90-101
174. Weinberger D.R., Berman K.F., and Daniel D.G. Prefrontal cortex dysfunction in schizophrenia. In: Levin H.S., et al. (Ed). Frontal Lobe Function and Dysfunction (1991), Oxford University Press, New York
175. Weiner I., and Feldon J. Reversal and nonreversal shifts under amphetamine. Psychopharmacology (Berl.) 89 3 (1986) 355-359
176. Winstanley C.A., Chudasama Y., Dalley J.W., Theobald D.E., Glennon J.C., and Robbins T.W. Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology (Berl.) 167 3 (2003) 304-314
177. Winstanley C.A., Theobald D.E., Dalley J.W., Glennon J.C., and Robbins T.W. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl.) 176 3-4 (2004) 376-385